RaySearch Laboratories AB (STU:27R) Margin of Safety % (DCF FCF Based): -217.31% (As of Jun. 29, 2026)


STU:27R RaySearch Laboratories AB STU:27R
83 GF Score
Price €18.88
GF Value €17.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Margin of Safety % (DCF FCF Based)?

RaySearch Laboratories AB STU:27R +1.56% 83 Margin of Safety % (DCF FCF Based) is -217.31% as of Jun. 29, 2026. GuruFocus rates STU:27R with a GF Score™ of 83/100 and a GF Value™ of €17.14 (Fairly Valued). The stock has 2 warning signs investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-29), RaySearch Laboratories AB's Predictability Rank is 2.5-Stars. RaySearch Laboratories AB's intrinsic value calculated from the Discounted FCF model is €22.81 and current share price is €18.88. Consequently,

RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -217.31%.

STU:27R vs VEEV, BTSG, TEM: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RaySearch Laboratories AB Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) falls into.


STU:27R
83GF Score
RaySearch Laboratories AB STU:27R
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Margin of Safety % (DCF FCF Based) Calculation

RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(5.95-18.88)/5.95
=-217.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of -217.31% mean?
RaySearch Laboratories AB (STU:27R) has a Margin of Safety % (DCF FCF Based) of -217.31% as of Jun. 29, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on RaySearch Laboratories AB.
Is RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) too high?
RaySearch Laboratories AB's current Margin of Safety % (DCF FCF Based) is -217.31%. Overall, RaySearch Laboratories AB has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) compare to VEEV and BTSG?
RaySearch Laboratories AB's Margin of Safety % (DCF FCF Based) of -217.31% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Healthcare Providers & Services company?
A good Margin of Safety % (DCF FCF Based) depends on the Healthcare Providers & Services industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on RaySearch Laboratories AB. RaySearch Laboratories AB's current Margin of Safety % (DCF FCF Based) is -217.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (STU:27R) is currently considered Fairly Valued. The stock's GF Value™ is €17.14, compared to a current price of €18.88 — trading 10.2% above its estimated fair value. The current Margin of Safety % (DCF FCF Based) is -217.31%. RaySearch Laboratories AB's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For RaySearch Laboratories AB (STU:27R), the current Margin of Safety % (DCF FCF Based) is -217.31% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (STU:27R) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of €18.88 is trading 10.2% above its estimated GF Value™ of €17.14. GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.

Key valuation signals for STU:27R:

  • Margin of Safety % (DCF FCF Based): -217.31%
  • GF Value™: €17.14 vs. price of €18.88 (10.2% above fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the STU:27R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
83GF Score

Get the complete analysis for STU:27R

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.88
Price
€17.14
GF Value